and public health resources. The spe cific reasons for this were explained in length in our article. One example is whether to screen all postmenopausal women at or after age 65 with BMD (level 1 evidence) or to modify this recommendation to account for an earlier development of osteoporosis in our population (according to local studies). Also, we felt it important to account for the clear difference in physical activities and therefore risk of falling between elderly females (above 65) in this region compared to the West. A more reasonable recom mendation in our view would be to start screening at an earlier age, and to incorporate risk factors to identify those at higher risk instead of drawing a fixed line that might fit other societ ies. In contrast, the use of anti-resorptive agents in patients with osteopenia without good evidence that it would decrease fracture rates seem less rea sonable in a society with widespread osteopenia but lower fracture rates than the West. A reasonable recom mendation in our view again would be to be more conservative in this group, and only to use such expensive treatment when there are fractures or high risk factors. Some international guidelines have recommended treat ment for such patients. In fact, there are significant differ ences in the recommendations made LETTERS by reputable international groups which make it impossible for a prac titioner to decide which one to follow. These differences are partially due to different circumstances, resources, views, and even interests. O ur task force final recommendations were, therefore, in general agreement with other international evidence-based guidelines. Modifications were only made when felt necessary by review ing local data.
Finally our attempt was, to our knowledge, the first of its kind in this region that attempted to deal with this ever expanding and often confus ing health problem. The guidelines are far from perfect, and obviously are limited by sparse local data and missing information on local risk fac tors and BMD/fracture correlation. Nevertheless, the guidelines have been very well received by local and even international specialists and practi tioners, and are largely adopted by the Saudi Osteoporosis Society, which is in the process of formulating national guidelines. To the E d ito r: Brucellosis is a zoonosis transmitted to humans from infected animals, mainly after consumption of unpasteurized milk and milk products and less often after direct contact with infected animals via in halation, especially by children and by slaughterhouse, farm, and laboratory workers.1,2 Although brucellosis in do mestic animals has been controlled in most developed countries it remains an important public health problem in several parts of the world. The dis ease is endemic in Iran6'8 as well as in other Middle East and mediterranean countries, and in Latin America.3 5 In a study in Iran most cases were caused by Brucella melitensis usually belong ing to biotype I.8 The aim of this study was to examine the epidemiological features, clinical and hematological characteristics, complications and treatment outcome of brucellosis in Yazd.
We reviewed the records of 686 patients 1 to 70 years of age with the diagnosis of brucellosis over a 6-year period between 1995 and 2001. The Nikoopour clinic is the center for in fectious diseases control in Yazd and is also the referral center for patients from other cities, mainly Maybod, Ardakan, Taft, Mehriz, and Sadough. Confirmed cases were defined those with clinical symptoms and signs sug gestive of brucellosis in which Brucella was recovered from blood. The pre sumptive diagnosis of brucellosis in patients with negative cultures was based on a standard tube agglutination titer (STA) (1:320. A Brucella abortus suspension was used for the STA test.
There was a significant difference in the number of patients during the 6 years of the study; the most were in 1998 with 266 cases (38.8%) and the least in 2001 with 18 cases (2.6%). Males were more commonly affected than females and the male-to-female ratio was 1.32. Only 3.2% of the pa tients were (5 years of age, and 23.8% were 5 to 14 years). A seasonal varia tion in the distribution of cases was observed, and the most common cases were observed in summer. Mean (±SD) duration of symptoms prior to diagno sis was 14.1 (±14.6) days (median 11 days, range 7-70 days).
Nearly all patients were febrile, most with moderate fever. Other common symptoms included fatigue, arthralgia, night sweats, gastrointesti nal manifestations such as abdominal pain and constipation and diarrhea and weight loss. A substantial number of patients (61%) developed arthritis or arthralgia. The joints more commonly affected included the knee in 49%, hip in 41%, ankle in 18%, wrist in 13%, and small joints of the hand in 15%. Monoarthritis and oligoarthritis was noted. A substantial number of patients (36%) developed sacroiliitis. Arthritis of the cervical spine was rare. The re sponse of joint symptoms to treatment was immediate and by two weeks of treatment nearly all patients had signif icant improvement. Hepatomegaly was reported in 5% patients. Splenomegaly was recorded in 20% cases and was also mild to moderate. Unilateral or bilat eral epididymoorchitis was seen in 11 (2.8%) cases in males.
The antibody titers to Brucella determined by standard tube ag glutination were as follows: 1/2560, 28 (4.08%); 1280,132 (19.24%); 1/640, 162 (23.62%); 1/320, 204 (29.74%); 1/160, 111 (16.18%); 1/80, 38 (5.54%); 1/40, 11 (1.6%). All of the patients had symptoms and signs suggestive of brucellosis. In patients who had an initial SAT titer of 1/80 the diagnosis was documented with a positive blood culture in 9 or with increased titer to 1/320 or greater on reexamination 1-2 weeks later.
All patients received a combination of two or three antibiotics. Duration of treatment was 8-12 weeks. None of the patients was readmitted to our clinic with a relapse. Only four patients had been previously treated in other places and presented for the first time to our clinic with a relapse. Two had received doxycycline and streptomycin for 2 weeks and two received doxycycline and rifampicin for 2 weeks. All four patients relapsed twice 1 to 2 months after discontinuation of therapy. They were then treated with doxycycline and streptomycin for 4 weeks and then with doxycyline and rifampin for 8 weeks and had no relapse during 6 months of follow-up.
Remarkable and unusual com plications were noted in two patients who developed chronic meningitis LETTERS and endocarditis. The first patient developed a prolonged history of fa tigue and weight loss and night sweats and low-grade fever. Blood cultures were negative and STA titer in the first 2 months was negative or 1/40. However, in the third month STA was detected at 1/640 and the CSF STA test was 1/80. The second patient presented with fever and sweats and weight loss, but the serum titer of the STA test was 1/40 and blood cultures were negative. However, one month after initiation of signs and symptoms the STA titer was detected at 1/640 and ultimately a heart murmur was detected.
Brucellosis is a systemic disease with protean manifestations. Its features may mimic those of other febrile illnesses. Brucellosis remains an important public health problem in our area and can cause serious compli cations, resulting in significant mor bidity. The clinical characteristics of brucellosis in our series are similar to those reported by previous studies.1,7 Musculoskeletal manifestations were recorded in the majority of patients and included arthralgia and arthritis, which most commonly affected the large joints of the lower extremities. Sacroiliitis was a frequent manifesta tion of brucellosis in our patients, but arthritis of the small joints of the hand was infrequent. The response of joint symptoms to treatment was immediate in our patients and none suffered long term complications.
The most common hematological manifestations of brucellosis in our group of patients were a normal CBC followed by anemia and lymphocytosis. These hematological manifestations of brucellosis have been reported in previ ous studies.1,2 Leukopenia was less fre quently encountered in our series.
A remarkable finding of the study was the insignificant STA titer (1/80) in a considerable number of patients (49, 7.14%), in whom the diagnosis was confirmed with a positive blood culture (9 cases) or with an increase in titer to 1/320 or greater on reexamina tion 1 to 2 weeks later. A falsely low or equivocal STA titer occasionally occurs in patients with acute brucellosis and the diagnosis can be made with the de tection of IgM antibodies with ELISA1' 9 or culture or repeat STA later. 12
Neurological complications of bru cellosis are uncommon1,10'12 and occur in <3%. In our study only one patient developed chronic meningitis. Blood cultures were negative and the STA titer in the first 2 months was (1/40). However, in the third month STA were detected at 1/640 and the CSF STA test was 1/80.
Our patients were treated with dif ferent therapeutic regimens and dura tion of treatment was variable since this was a retrospective study spanning 6 years. However, none of the patients who received a combination of rifampicin plus either doxycycline or trim ethoprim-sulfamethoxazole ± strepto mycin (for the first month) for 8 weeks or longer had a relapse. Therefore, it appears that the combination of at least two of the above antibiotics for a period of 8 weeks is an effective treat ment for brucellosis. The patients who presented with a relapse had previously received a combination of two antibi otics for 2 weeks. The relapse occurred in these patients within 1 to 2 months from completion of initial treatment. High relapse rates have been reported with short-term (3 week) two-drug regimens even when an aminoglycoside was initially included.7'14
In conclusion, brucellosis has a wide range of clinical manifestations. It may affect any organ system and imitate a variety of clinical entities. Physicians practicing in endemic areas must be familiar with this disease so that early recognition results in lower morbidity. The diagnosis may present difficulties since blood cultures or the agglutination test may not always be positive. Treatment with at least two antibiotics for not less than eight weeks appears to be effective. An organized effort must be undertaken in endemic 
LETTERS
A 2900-g baby showed symptoms of hypotonia, tachypnea and difficulty in feeding on the third day of his rou tine care in the maternity ward of our clinic after an uneventful vaginal delivery. W ith these symptoms, the patient was screened for sepsis. All the culture results were negative after 48 hours. O n the 4th day, he developed left-sided clonic convulsions. The seizures did not respond to intrave nous dormicum (midazolam) and phenytoin. Arterial blood gas analysis was normal. Blood was taken for se rum ammonia level and a metabolic screen. Subsequent development of apnea and dilated poorly responsive pupils led to intubation and mechani cal ventilation. Laboratory results included severely elevated ammonia (619 mol/L). The citrulline level was extremely elevated by the tandem mass spectrophotometer and the uri nary citrulline level was also found to be extremely elevated. No peak belonging to argininosuccinic acid was seen. Quantitative analysis of plasma amino acids revealed citrulline to be 1142 pmol/L (10-45) which was extremely elevated. The patient was treated by hemodialysis and enteral sodium benzoate because of his high ammonia level.
Because citrullinemia can be as sociated with multiple congenital anomalies and organ disease, an ultrasonographic (US) evaluation of the cranium and abdomen was per formed.
Cranial US was normal. The abdominal US revealed calculi at the distal end of the left ureter and right renal pelvis.There was a history of pa rental consanguinity. The patient was lost on the tenth day of admission to the neonatal intensive care unit due to encephalopathy.
Argininosuccinic acid synthetase deficiency (ASD) is a rare disorder of urea cycle metabolism, with pro nounced citrullinemia.1 The progno sis depends on early diagnosis, which is based on clinical suspicion and analytical determination of ammonia in every newborn with unexplained vomiting, lethargy or other symptoms of encephalopathy.2
Many anomalies and organ disease have been reported in surviving citrul linemia cases, including transposition of the great arteries, subarachnoid hemorrhage, intracranial anomalies, intrahepatic cholestasis, and cutane ous manifestations are some of the anomalies reported in the literature.1* 4 In conclusion we want to emphasize the association of the disease with uro lithiasis so that renal calculi are kept in mind in cases who survive. 
